Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Manouchkathe Cassagnol"'
Autor:
Roman Zeltser, Manouchkathe Cassagnol, Amgad N. Makaryus, Ofek Hai, Shaqeel A Sherali, Kyla D'Angelo, David Bass
Publikováno v:
World Journal of Cardiology
BACKGROUND Statins have an important and well-established role in the prevention of atherosclerotic cardiovascular disease (ASCVD). However, several studies have reported widespread underuse of statins in various practice settings and populations. Re
Autor:
Leigh Boehmer, Adrienne Drucker, Hani M. Babiker, Ali McBride, Mollie Gowan, Todd D. Camenisch, Faiz Anwer, James M. Hollands, Manouchkathe Cassagnol, Michael Newton
Publikováno v:
Critical Reviews in Oncology/Hematology. 126:186-200
Cardiotoxic effects of chemotherapy and targeted drugs are ubiquitous and challenging in the field of oncology therapeutics. The broad spectrum of toxicities ranging from ischemic, hypertensive, cardiomyopathic, and arrhythmic complications can prese
Autor:
Manouchkathe Cassagnol, Om Talreja, Chester Lam, Amgad N. Makaryus, Ilana Fuzaylova, Deborah Ahern
Publikováno v:
Journal of pharmacy practice. 33(5)
Sacubitril/valsartan (Entresto®) is the first commercially available angiotensin receptor neprilysin inhibitor (ARNI) approved for use in heart failure patients with a reduced ejection fraction. It is a combination drug that contains sacubitril, a n
Autor:
Roman Zeltser, Peter Wenn, Demian Jideofor Omeh, Ashley Roper, Xiu Qing Lin, Yea Wilson, Amgad N. Makaryus, Andres Castillo, Michelle K. Ponto, Yerin Yang, Manouchkathe Cassagnol, Wenchen Wu, Ofek Hai
Publikováno v:
Journal of the American College of Cardiology
Publikováno v:
INTED proceedings.
Publikováno v:
Journal of Pharmacy Practice. 26:528-540
Hypercholesterolemia affects over 34 million adults in the United States and is a major cause of coronary heart disease (CHD). Conventional therapies, such as statins, have demonstrated their ability to improve clinical end points and decrease morbid
Publikováno v:
The Consultant Pharmacist. 25:739-744
OBJECTIVES Determine the influence of warnings from the Food and Drug Administration (FDA) regarding antipsychotic use for the management of dementia-related psychosis on clinical practice. DESIGN/SETTINGS/PARTICIPANTS A survey of health care profess
Autor:
Richard Perry, Manouchkathe Cassagnol
Publikováno v:
Clinical Therapeutics. 31:1374-1404
Background: Desvenlafaxine succinate, a serotonin—norepinephrine reuptake inhibitor (SNRI), was approved by the US Food and Drug Administration (FDA) in February 2008 for the treatment of adult patients with major depressive disorder (MDD). Desvenl
Autor:
Gregory J. Hughes, Mary Ann Howland, Gladys M. El-Chaar, Candace Smith, Manouchkathe Cassagnol, Donna Sym, Wenchen Wu
Publikováno v:
American journal of pharmaceutical education. 78(5)
Objective. To determine if the addition of weekly quizzes or reducing the number of faculty members teaching improved third-year (P3) pharmacy students’ final grades in a clinical pharmacokinetics course. Design. Four sections of a pharmacokinetics
Publikováno v:
Journal of pharmacy practice. 24(4)
Hyponatremia is a very common electrolyte abnormality. Dilutional hyponatremia is very difficult to treat effectively due to the complications of conventional treatment. Arginine-vasopressin (AVP) plays an integral role in circulatory and water homeo